Rapid Micro Biosystems, Inc. (RPID) has a MoatMap StockRank of 2/100 based on Quality (21/100), Value (37/100), and Momentum (16/100) factor scores. The current signal is STRONG SELL. Rapid Micro Biosystems provides microbial detection automation. While automation is a theme, the company is small, unprofitable, and lacks the pricing power or scale of a validated CDMO or major life sciences tool provider.
Rapid Micro Biosystems, Inc. develops and sells automated microbial detection systems, primarily for quality control applications within the pharmaceutical industry. Its flagship Growth Direct® System offers a significant competitive advantage by accelerating microbial enumeration and detection, reducing manual labor and time-to-result. This positions the company as a key innovator in pharmaceutical quality control and manufacturing efficiency.
| Price | $1.88 |
| Market Cap | $101M |
| P/E (Forward) | -2.52 |
| Price/Book | 4.43 |
| Return on Equity | -116.7% |
| Return on Invested Capital | -81.6% |
| Debt/Equity | 22.83 |
| Gross Margin | 2.9% |
| Operating Margin | -173.1% |
| Revenue Growth | 11.1% |
Rapid Micro Biosystems, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).